Author: Operations Team

New York, NY – May 26, 2026 – In a challenge brought by BBB National Programs’ National Advertising Division, Rapid Consulting, LLC (Rapid Radios) was found to have a reasonable basis for its claim “Legal to Own with no FCC License Required” for its My Emergency Radio.

Rapid Radios is a family-owned business that markets and sells My Emergency Radio, an amateur radio.

At issue for the National Advertising Division (NAD) was whether the claim, “Legal to Own with no FCC License Required,” is supported under applicable Federal Communications Commission (FCC) regulations.

NAD determined that the claim is supported in the context of amateur radio use, as an FCC license is not required when the radio is operated during an emergency. In addition, Rapid Radio’s agreement to comply with the Advertising and Voluntary Compliance (AVC) from the Michigan Attorney General’s Office, which addressed some of the challenged advertising claims, including disclosure of relevant FCC usage requirements, will help ensure that consumers are informed of the applicable FCC rules.

During the inquiry, Rapid Consulting informed NAD that it had permanently discontinued certain challenged claims related to its sales and technology. NAD will treat the discontinued claims, for compliance purposes, as though NAD recommended their discontinuance and the Advertiser agreed to comply.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.

New York, NY – May 26, 2026 – In a challenge brought by Eli Lilly and Company, BBB National Programs’ National Advertising Division recommended that Noom, Inc. modify or discontinue its Microdose GLP-1^RX Program “A Smaller Dose. A SmarterStart” claim.

Lilly and Noom compete in the weight-loss market. Lilly markets tirzepatide-based prescription medications Mounjaro® and Zepbound®. Noom is a weight-loss platform that offers GLP-1 medications in conjunction with its behavior-change program.

At issue for the National Advertising Division (NAD) was whether the claim “Noom GLP-1Rx Program A Smaller Dose. A Smarter Start. Microdose GLP-1Rx Starts at $119*.” constituted non-actionable puffery or, in context, conveyed an objective health-related message requiring substantiation.

NAD determined that one message reasonably conveyed by the challenged claim is that Noom’s product is “smarter” due to its “smaller” dose, and that the smaller dosage provides a measurable, health-related benefit, which requires substantiation.

NAD found that Noom did not provide adequate support for the message that Noom’s specific lower-dose approach provides a measurable health-related benefit that makes it a “smarter start.”

Accordingly, NAD recommended that Noom discontinue the claim “NOOM GLP-1Rx PROGRAM A Smaller Dose. A Smarter Start. MICRODOSE GLP-1Rx STARTS AT $119*” or modify its advertising to avoid conveying the message that the lower dose of medication provided by the Noom Microdose GLP-1Rx Program itself provides a measurable, health-related benefit that makes it a smarter or better way to begin treatment.

NAD noted that nothing in its decision precludes Noom from promoting its program or the benefits of its behavior-modification tools as a smarter start, provided the advertising does not tie that message to unsupported dosage-related benefits.

During the inquiry, Noom informed NAD that it was permanently discontinuing all other challenged express claims, including dosing, efficacy, side effect, and other health-related claims. Based on Noom’s representation that the discontinued claims were being permanently discontinued, NAD did not review them on their merits and will treat the permanently discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

In its advertiser statement, Noom stated that while it “disagrees with NAD’s conclusion,” it “voluntarily agrees to comply with NAD’s recommendation.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Pursuant to NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.

Managed care organizations join to bring strength and stability to North Carolina’s public system of behavioral healthcare

Asheville/Gastonia, N.C. – Today, North Carolina Department of Health and Human Services Secretary Devdutta Sangvai approved the consolidation of Vaya Health and Partners Health Management, contingent upon completion of a successful readiness review. The merger brings together two established Local Management Entity/Managed Care Organizations (LME/MCOs) with decades of service to North Carolina communities. Secretary Sangvai’s approval follows formal action by the Boards of Directors of both Vaya Health and Partners Health Management to adopt consolidation resolutions.

The consolidation will be effective Oct. 1, 2026, creating North Carolina’s largest publicly governed behavioral health organization dedicated to integrated, whole-person care for North Carolinians with complex needs related to mental health, substance use disorders, intellectual/developmental disabilities (I/DD), and traumatic brain injuries (TBI).

The new organization will operate under the name Vaya Partners, reflecting complementary capabilities, shared values, and a joint commitment to continuing their decades of service to members, families, providers, counties, and communities.

Vaya Partners will serve more than 222,000 members across 47 counties, creating a balanced and sustainable regional model that supports the long-term viability of North Carolina’s public behavioral health system. The consolidation also establishes a more connected and cohesive region that better reflects how care is delivered and how communities function, positioning the public system to more effectively meet the needs of those it serves.

“Our highest priority is and always will be the health, safety, and well-being of the members and recipients we are privileged to serve,” said Tracy Hayes, Area Director and Chief Executive Officer of Vaya Health. “This merger represents a shared vision of a stronger health plan that will bolster North Carolina’s public behavioral health/IDD/TBI system, support our county partners, and serve even more North Carolinians on their journey toward health and wellness.”

The combined organization will be led by an experienced executive team drawn from both Vaya Health and Partners Health Management, ensuring continuity, stability, and deep expertise across the region. Tracy Hayes, current Area Director and Chief Executive Officer of Vaya Health, will serve as Area Director and Chief Executive Officer of Vaya Partners. Libby McCraw, Chief Executive Officer of Partners Health Management, will assume the role of Senior Deputy CEO. Rachel Porter, Deputy CEO of Partners Health Management, will continue as Deputy CEO.

“This consolidation brings together the strength, experience, and shared commitment of both organizations to better serve members and communities across North Carolina,” said Libby McCraw, Chief Executive Officer of Partners Health Management. “At the center of that work are our employees, whose dedication and expertise are the driving force behind the care and support we provide every day. We will build on that foundation, broaden our reach, and deliver even greater impact for members, families, providers, and communities. Together, we are advancing our shared commitment to Improving Lives and Strengthening Communities.”

Individuals who receive services through Vaya or Partners will not experience changes to their benefits or providers. Contracted providers will continue to operate as they do today, with no immediate changes to participation, billing, or administrative processes. Leadership from both organizations will work closely with the North Carolina Department of Health and Human Services, as well as state and local partners, to ensure continuity of care and a successful transition that puts member, provider, and community needs at the forefront.

About Vaya Health

Vaya Health is a specialty managed care organization and local government agency that oversees publicly funded health care services across a 32-county region of North Carolina for people with significant behavioral health needs, intellectual/developmental disabilities, and traumatic brain injuries. Vaya manages Medicaid, federal, state, and local funding to meet member and community needs while advancing whole-person health. Together with members, contracted providers, and local partners, we’re moving forward to a healthier North Carolina. Vaya Health can be found online at vayahealth.com, on Facebook at facebook.com/VayaHealth/, on X (formerly known as Twitter) @VayaHealth, on Instagram at instagram.com/vaya.health, and on LinkedIn at linkedin.com/company/vaya-health.

About Partners Health Management

Partners Health Management plays a critical role in ensuring access to comprehensive, high-quality care for Medicaid beneficiaries and uninsured/underinsured individuals across 15 North Carolina counties. We strategically manage Medicaid, state, and local funds to support whole-person, integrated physical and behavioral health care for individuals receiving mental health, intellectual and other developmental disability, substance use disorder and traumatic brain injury services. Partners is widely recognized across North Carolina for our innovative Partners Community Model, which is rooted in localized, person-centered care shaped by the voices of the individuals and families we serve. Our enduring partnerships with providers, community organizations, and stakeholders reflect our unwavering commitment to fostering collaboration and delivering measurable results. Together, we are advancing our mission of Improving Lives and Strengthening Communities, one member at a time. Partners can be found online at partnersbhm.org, on Facebook, Instagram, X (formerly Twitter), LinkedIn, and on YouTube.

Contact Information:

Vaya Health

Allison Inman
allison.inman@vayahealth.com

Partners Health Management

Rachel Porter
rporter@partnersbhm.org

New York, NY – May 21, 2026 – A panel of the National Advertising Review Board (NARB), the appellate advertising body of BBB National Programs, has recommended that Niagen Bioscience, Inc. discontinue or modify several health-benefit advertising claims for its Tru Niagen line of nicotinamide riboside (NR) dietary supplements.

The underlying National Advertising Division (NAD) decision (Case #7487) was initiated by Reus Research LLC, a competitor in the dietary supplement industry. Niagen appealed NAD’s recommendation to modify or discontinue challenged express and implied claims for the Tru Niagen dietary supplement, including certain health-benefit, establishment, structure/function, and ‘clinically proven’ claims.

Regarding establishment claims, the panel agreed with NAD that the relied-upon clinical studies did not support the claim asserting that specified increases in NAD+ levels following use of Tru Niagen had been clinically proven for the general population.

For health-benefit claims, the panel noted that while Niagen argued these were “structure/function” claims permissible under the Dietary Supplement Health and Education Act (DSHEA), the required substantiation depends on the message conveyed to consumers, not the advertiser’s regulatory classification. The panel agreed with NAD and found that many of Niagen’s claims went beyond cell-level mechanistic effects to promise perceptible or functional health benefits that were not properly supported.

The NARB panel determined that NAD’s decision should be affirmed and recommended that Niagen discontinue its “clinically proven” establishment claims, as well as specific health-benefit claims, including those related to heart, brain, and immune health.

The panel further recommended that Niagen discontinue anti-aging claims and consumer testimonials that communicate perceptible, real-world improvements, as well as muscle health and energy-related claims that promise functional recovery or vitality benefits.

Regarding modification, the panel noted that certain claims phrased in biological or cellular terms should not be used in a context that conveys a message of a perceptible or functional health benefit.

In its advertiser statement, Niagen stated that it is “deeply disappointed with the NARB Panel’s decision but will nevertheless comply” with NARB’s recommendations.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Review Board (NARB): The National Advertising Review Board (NARB) is the appellate body for BBB National Programs’ advertising self-regulatory programs. NARB’s panel members include 85 distinguished volunteer professionals from the national advertising industry, agencies, and public members, such as academics and former members of the public sector. NARB serves as a layer of independent industry peer review that helps engender trust and compliance in NAD, CARU, and DSSRC matters.

New York, NY – May 20, 2026 – A panel of the National Advertising Review Board (NARB), the appellate advertising body of BBB National Programs, has referred Intervet, Inc. (d/b/a Merck Animal Health) to the Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) for failure to comply with its recommendation to discontinue or modify express once-a-year dosing claims for its Bravecto® Quantum injectable flea and tick treatment for dogs. 

Merck Animal Health appealed the National Advertising Division’s (NAD) (Case #7519) recommendation that Merck Animal Health discontinue or modify its express Bravecto Quantum once-a-year dosing claims, which included claims that a “quick injection” provides “1 full year* of flea and tick protection for dogs” and offers “365 days of protection, all in one dose.” The challenger in the case is Elanco Animal Health, Inc.

The NARB panel found that Merck’s express once-a-year dosing claims are inaccurate and misleading. While the first FDA-approved indication for the product provides 12 months of protection against multiple tick species in a single dose, the FDA-approved dosing interval to protect dogs from one tick species, the lone star tick, is eight months. The panel concluded that the advertising conveys to veterinarians and consumers that dogs are protected from ticks for a full year regardless of the species, placing the burden on the user to figure out the limits of the broad dosage claim.

Additionally, the panel found that website graphics identifying the tick species covered by the once-a-year dosing claim did not distinguish the lone star tick from others, and that the asterisk used in headlines referring to a statement that Bravecto Quantum also kills lone star ticks for 8 months was not noticeable. Consequently, the NARB panel recommended that Merck Animal Health discontinue the express once-a-year dosing claims or modify them to clearly communicate “up to” one year of protection in the main claim, accompanied by a clear and conspicuous disclosure in close proximity explaining that certain tick species require more frequent dosing under the FDA-approved indication.

The panel noted that it did not agree with NAD that the qualification regarding the lone star tick must be in the main claim, finding that specific recommendation too prescriptive, provided the “up to” language and a clear disclosure are used instead.

In its advertiser statement, Merck Animal Health agreed to use a clear and conspicuous disclosure, in close proximity to the main dosing claim, conveying that Bravecto Quantum should be dosed every eight months when used to target Amblyomma americanum (lone star ticks).

Merk Animal Health, however, declined to implement NARB’s recommendation to modify the main dosing claim, stating the recommendation would “require Merck Animal Health to approach tick claims differently than its competitors and unfairly restrict promotion of Bravecto Quantum’s first FDA-approved indication.” Therefore, this matter has been referred to the FTC and FDA for possible enforcement action.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Review Board (NARB): The National Advertising Review Board (NARB) is the appellate body for BBB National Programs’ advertising self-regulatory programs. NARB’s panel members include 85 distinguished volunteer professionals from the national advertising industry, agencies, and public members, such as academics and former members of the public sector. NARB serves as a layer of independent industry peer review that helps engender trust and compliance in NAD, CARU, and DSSRC matters.

New York, NY – May 20, 2026 – In a Fast-Track SWIFT challenge brought by Dyson, Inc., BBB National Programs’ National Advertising Division recommended that SharkNinja Operating, LLC modify its “Clean Air 100%” advertising for the Shark NeverChange Air Purifier MAX to clearly and conspicuously disclose the basis for the claim.  

Fast-Track SWIFT is an expedited process for single-issue advertising cases reviewed by the National Advertising Division (NAD).  

Dyson and Shark sell competing household air purifiers. At issue for NAD were the “Clean Air 100%” claims, which appear on product packaging and in various advertisements, and whether the challenged advertising lacks appropriate disclosure for Shark’s “Clean Air 100%” claim.  

NAD determined that a claim of “Clean Air 100%” may be reasonably understood by consumers to mean that the surrounding air is 100% free of all pollutants. NAD further determined that Shark’s existing disclosures did not sufficiently communicate that the “100%” reading represents the sensor’s lowest detectable level of particulate matter rather than the removal of all impurities in the air.  

To avoid conveying the message that the NeverChange eliminates all impurities in the air, NAD recommended Shark clearly and conspicuously disclose the basis for the claim when the phrase “Clean Air 100%” is clearly visible and used in conjunction with related performance claims or is otherwise prominently displayed or magnified. NAD noted that in certain advertising, the display may be obscured, or only the number “100” is visible, with no other context provided relating the display to product performance. In such instances, no disclosure may be necessary. 

During the challenge, Shark informed NAD that it had permanently discontinued advertising depicting a progression from 40% to 70% to 100%. Based on this voluntary permanent modification, NAD did not address the merits of this specific iteration, and for compliance purposes, it will be treated as if NAD recommended they be discontinued and Shark agreed to comply. 

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes. 

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.

New York, NY – May 18, 2026 – In a Fast-Track SWIFT challenge brought by Human Interest Inc., BBB National Programs’ National Advertising Division found that Vestwell Holdings Inc. provided sufficient information regarding its recent acquisition of Accrue 401k, but recommended that certain claims regarding its Annual Recurring Revenue (ARR) be modified to include a clear and conspicuous disclosure of the methodology used to calculate that figure.

Fast-Track SWIFT is an expedited process for single-issue advertising cases reviewed by the National Advertising Division (NAD).

Vestwell and Human Interest compete in the workplace savings market, offering 401(k) plans and other products to businesses and their employees. At issue for NAD was whether Vestwell’s ARR claims in its press release require disclosure of the methodology used to calculate ARR and the extent to which the reported ARR includes ARR from a recent acquisition.

NAD found that, in the context of the press release, it was not necessary to require any specific disclosure of the extent to which the ARR figure is attributable to the recent acquisition. The press release includes a reference to the Accrue acquisition, with a bullet point stating “Nearly 30,000 plans added through the Accrue 401k acquisition,” a hyperlink to the press release announcing the acquisition. Thus, there was sufficient information in the press release to inform consumers that the reported ARR figure is inclusive of growth through acquisition.

However, regarding the ARR claims, NAD determined that the press release may be relied upon by potential customers to compare providers, as with any other advertising format, and that a succinct disclosure describing the method used to calculate ARR allows those potential customers to assess the claimed revenues for comparative purposes.

Therefore, NAD recommended Vestwell modify the claims “The Series E doubles Vestwell’s valuation as the company surpasses 2 million active savers, $50 billion in assets, and $200 million in annual recurring revenue,” and “Vestwell has surpassed $200 million in annual recurring revenue and continues to grow profitability” to include a clear and conspicuous disclosure of the methodology used to calculate the reported ARR.

In its advertiser statement, Vestwell stated that though it disagrees with certain elements of the decision, it will “comply with NAD’s recommendations.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.

New York, NY – May 14, 2026 – In a challenge brought by Calyx Containers, LLC, BBB National Programs’ National Advertising Division recommended that Kinzie Advanced Polymers, LLC, d/b/a Grove Bags, modify certain express and implied claims for its TerpLoc® cannabis storage products.

Calyx Containers and Grove Bags compete in the cannabis packaging industry offering specialized, high-performance storage solutions designed to preserve product quality. At issue for the National Advertising Division (NAD) were advertising claims across multiple media channels related to humidity control, weight retention, and terpene preservation for Grove Bags’ TerpLoc® cannabis curing and storage products.

NAD found that Grove Bags’ internal testing and independent third-party studies provided a reasonable basis for claims that TerpLoc® packaging functions as an effective passive modified atmosphere packaging (MAP) system that maintains moisture stability and preserves cannabinoids and terpenes better than conventional storage methods when following product use instructions.

However, NAD determined that the moisture stability and terpene preservation claims are expressly dependent on specific conditions of use and found that the evidence does not directly establish that TerpLoc® packaging consistently maintains a precise relative humidity range of 58–62% under all conditions.  

NAD recommended that Grove Bags modify its advertising to clearly and conspicuously disclose the conditions under which the claimed results can be achieved and to avoid language suggesting guaranteed or universal performance.

NAD also determined that the ads, in context, do not reasonably convey the challenged implied message that Grove Bags regulate the relative humidity to the claimed level, no matter the level of moisture of the product when placed in the bag.

NAD found that the product’s instructions for use are material terms that must be clearly and conspicuously disclosed in close proximity to the performance claims. NAD found that the challenged claims without qualification, that the bags will “create” a specific microclimate to achieve the advertised relative humidity (RH) or that the bags “ensure” weight retention and terpene preservation, were not supported.  

During the proceeding, Grove Bags voluntarily discontinued claims related to mold prevention. These claims will be treated for compliance purposes, as though NAD recommended they be discontinued.

In its advertising statement, Grove Bags stated, “it will comply with NAD’s recommendations.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.

Protégé uses AI to immediately turn plain-language questions into strategic business insights grounded in trusted data and transparent reasoning

New York, NY – May 13, 2026 – LexisNexis^® Legal & Professional, a leading global provider of AI-powered analytics and decision tools, today announced the launch of Protégé in LexisNexis PatentSight+, a powerful AI assistant that helps professionals quickly analyze data across tens of millions of harmonized and verified patent records to uncover relevant, and actionable business insights within minutes.

LexisNexis Protégé is purpose-built for patent intelligence. It allows professionals to ask plain language questions, without any complex filters or queries, and receive reliable, decision-ready insights. Integrated with PatentSight+ and based on trusted data, analytics, and industry-established metrics, including LexisNexis^® Patent Asset Index methodology, Protégé provides a structured starting point for deeper analysis. It keeps professionals in the driver’s seat by explaining every step of the analysis, displaying the full queries, contextualizing results, and suggesting next steps, with full transparency into how insights are generated so they can be easily understood and validated.

“Protégé fundamentally changes how organizations work with patent data by replacing complicated filters with simple questions, so business leaders can easily get timely, verifiable, and valuable insights to inform their strategic business decisions,” said Andrew Matuch, president for LexisNexis^® Intellectual Property Solutions. “Protégé helps experienced patent professionals do their jobs better and get more done in less time, while expanding access to patent data to key players in other parts of the organization.”

Protégé was developed in close collaboration with hundreds of the world’s leading innovators through the LexisNexis^® AI Insider program. Feedback from PatentSight+ users with early access to the AI tool helped refine its agentic reasoning, and shape Protégé to reflect the best-practice workflows of highly skilled IP analysts. Users also reported that Protégé reduces manual analysis effort by up to 70 to 90 percent and enables them to deliver up to 3x more output while maintaining trustworthy and transparent results.

“What I find most valuable about Protégé is seeing how it reasons through a problem,” said Christopher Hauke, Head of Strategic IP and Innovation, Schott Pharma AG & Co. KGaA. “It makes the analysis transparent and gives me confidence in the results. By bringing together patent data and business context in one place, it’s much easier to connect what’s happening in the market with what I see in the data. It also gives me a clear starting point, instead of figuring out where to begin, I immediately see the key insights and where to dig deeper.”

Protégé also democratizes access to patent intelligence beyond traditional IP teams, so patent data and analytics can be used by other executives to support high-value business decisions such as competitive positioning, R&D strategy, and M&A, partnership or licensing evaluations.

Protégé presents results through clear, presentation-ready visualizations, including charts and graphics that follow common formats for annual reports, strategy documents, corporate communications, and media coverage, so teams across IP, corporate strategy, competitive intelligence, legal and other functions can communicate insights more effectively to the C-suite or other internal and external stakeholders.

With Protégé in PatentSight+, organizations can:

• • Turn business questions into structured analysis instantly
  • Reduce manual effort and accelerate time to insight from hours or days to minutes
  • Identify competitive threats and strategic opportunities faster
  • Generate clear, executive-ready outputs to support decision-making
  • Expand access to patent intelligence beyond technical experts

The launch of Protégé in PatentSight+ reflects growing demand for faster, more transparent ways to turn complex data into actionable business insights. Protégé is available now, both as an add-on for existing customers and as part of the core offering for new subscriptions, enabling organizations to immediately extend their existing workflows with AI-powered patent analytics.

More about Protégé in PatentSight+: https://www.lexisnexisip.com/protege/

About LexisNexis^® Legal & Professional

LexisNexis^® Legal & Professional provides AI-powered legal, regulatory, business information, analytics, and workflows that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis^® and Nexis^® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,900 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

About LexisNexis^® Intellectual Property Solutions

LexisNexis^® Intellectual Property Solutions brings clarity to innovation for businesses worldwide. We enable innovators to accomplish more by helping them make informed decisions, be more productive, comply with regulations, and ultimately achieve a competitive advantage for their business. Our broad suite of workflow and analytics solutions, including LexisNexis^® PatentSight+ with LexisNexis Protégé, LexisNexis^®Classification, LexisNexis^® TechDiscovery, LexisNexis^® IPlytics, LexisNexis PatentOptimizer^®, LexisNexis PatentAdvisor^®, and LexisNexis TotalPatent One^®, LexisNexis^® IP DataDirect, enables companies to be more efficient and effective at bringing meaningful innovations to our world.
By combining trusted, enriched data, industry-proven metrics, and AI-powered capabilities such as Protégé, we help organizations turn complex intellectual property data into clear, actionable insights that support confident strategic decision-making. We are proud to directly support and serve these innovators in their endeavors to better humankind. 

Media Contact:

Andrew Weinstein 
Andrew.Weinstein@LexisNexis.com

LexisNexis^®  |  Intellectual Property Solutions

Bringing clarity to innovation